Dezima Pharma
Latest round
- Series A
Last raised
- Feb 2013
Total raised
- $13M
Investors
- 3
About Dezima Pharma
Founded in 2012 and based in Naarden, Netherlands, Dezima Pharma BV operates as a biotechnology company that develops novel drugs to treat cardiovascular disease related to dyslipidemia.
Who invested in Dezima Pharma
3 investors across 2 rounds
See all investors in Dezima Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Dezima Pharma
Who invested in Dezima Pharma?
Dezima Pharma has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dezima Pharma raised?
Dezima Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Dezima Pharma last raise money?
Dezima Pharma's most recent round on record is a Series A, in Feb 2013.
What does Dezima Pharma do?
Founded in 2012 and based in Naarden, Netherlands, Dezima Pharma BV operates as a biotechnology company that develops novel drugs to treat cardiovascular disease related to dyslipidemia.
Where is Dezima Pharma headquartered?
Dezima Pharma is headquartered in Naarden, Netherlands.
Which VCs invest in companies like Dezima Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Dezima Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Dezima Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.